View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ahold Delhaize: Peer Walmart 4Q25/26 results. Arcadis: Main topics 4Q25/FY25 conference call. ASM: 4Q25 preview, FY26 should be strong. Brunel: 4Q25 result beats and trends stabilise; DACH back to growth in 1Q26; additional cost savings announced and special dividend. Cofinimmo: Beat on bottom line, strong investment outlook for 2026. IMCD: Another step in EMEA. Magnum Ice Cream Company: Peer Danone 4Q25 results. Recticel: Peer Kingspan FY25 results. Software sector: Cheaper code...

Kristof Samoy
  • Kristof Samoy

Arcadis Key take-aways analyst call

This morning Arcadis reported numbers (as written in a separate FRN) that were disappointing. Only the Resilience GBA and the cash collection process delivered in 4Q25. The sharp revenue revision for 2026 came as a cold surprise but the new CFO delivered on his cash collection commitment made late 2025. Together with the CEO nominee he outlaid a hands-on, pragmatic approach for a return to meaningful topline and margin growth. However this will be (again) back-end loaded in 2026 and mainly reali...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

AEGON: Uneventful results, US weaker, underlying OCG in line / Air France-KLM: Productivity gains starting to filter through / Arcadis: Weak revenues and EBITA, but strong NWC / Ascencio: Results in line, no concerns on Carrefour Belgium exposure / Azelis: Persisting softness in 4Q25, continued focus on costs and cash / BAM Group: Solid 2H25 results, 2026 outlook in line / Belgian telecoms: Telenet improved net adds, to relist as part of Ziggo in 2027, Liberty to sell half of its 66% Wyre stake ...

Kristof Samoy
  • Kristof Samoy

Arcadis First look: Only Resilience & cash collection delivered in 4Q2...

Arcadis released a disappointing set. Only Resilience posted an inline performance. Growth in Places in 4Q was -13% while our scenario was counting on a stabilisation (o% y/y). 4Q Traction in Mobility did not materialise as expected. Company guides for a transitional 2026 with flat growth well below our and css est. . Thanks to strong cash collection FCF was a clear positive surprise. Analyst call at 2pm CET. We will adjust our 2026 numbers downwards to the issued guidance. Hold.

Guy Sips ... (+9)
  • Guy Sips
  • Hilde Van Boxstael
  • Kristof Samoy
  • Mathijs Geerts Danau
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Morning Notes : ABI BB, AGN NA, ARCAD NA, BESI NA, ENX FP, GIMB BB, HY...

: ABI BB, AGN NA, ARCAD NA, BESI NA, ENX FP, GIMB BB, HYL BB, IBAB BB, KIN BB, MTLS US, VGP BB, AZE BB, ZEAL DC

Martijn Den Drijver
  • Martijn Den Drijver
 PRESS RELEASE

Arcadis Q4 and Full Year 2025 Results: Mixed results, repositioning fo...

Arcadis Q4 and Full Year 2025 Results: Mixed results, repositioning for next growth phase PRESS RELEASE | Arcadis Fourth Quarter and Full Year Results 2025 Mixed results, repositioning for next growth phase FOURTH QUARTER Net revenues of €887 million, organic growth of -2.9%Operating EBITA margin of 10.8% (Q4‘24: 12.6%)Extensive Property & Investment (within Places) project portfolio review led to revenue adjustments Record free cash flow performance of €344 million (Q4‘24: €183 million) FULL YEAR Net revenues of €3.8 billion, organic growth -0.5% with areas of strength offset by Place...

 PRESS RELEASE

argenx to Report Full Year 2025 Financial Results and Fourth Quarter B...

argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026 February 19, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, February 26, 2026 at 2:30 PM CET (8:30 AM ET) to discuss its full year 2025 financial results and provide a fourth quarter business update. A webcast of the live call may be accessed on the Investors section of th...

Guy Sips ... (+2)
  • Guy Sips
  • Michiel Declercq
Guy Sips
  • Guy Sips

Biotalys Model update after strategic refocus

We updated our model (New “Accumulate”, New € 5.1 TP) after Biotalys plans a strategic refocus, concentrating resources on its top-priority biofungicide programs. Early-stage activities will be suspended and the organization downsized to cut costs while they claim “protecting long-term platform value”. The shift prioritizes Evoca NG, BioFun-6, and already partnered programs with the Gates Foundation and Syngenta. These measures aim to reduce cash burn by €20m through 2028 and strengthen commerci...

Guy Sips
  • Guy Sips

Biotalys Refocusing strategy on lead assets and cutting annual cash bu...

We will update our model (from “Buy” to “under review”) after Biotalys plans a strategic refocus, concentrating resources on its top-priority biofungicide programs. Early-stage activities will be suspended and the organization downsized to cut costs while protecting long-term platform value. The shift prioritizes EVOCA NG, BioFun-6, and already partnered programs with the Gates Foundation and Syngenta. These measures aim to reduce cash burn by €20m through 2028 and strengthen commercialization r...

Guy Sips ... (+10)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Livio Luyten
  • Lynn Hautekeete
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List Update February 2026: Removing ASMi; Adding UCB

After today's changes (ASMi out, UCB in), we maintain a balanced approach in our Dynamic Top Pick List, with a particular emphasis on value stocks that have been overlooked. Our defensive holdings are overweight, including real estate, which stands to benefit from lower interest rates. We remove ASMi from our Dynamic Top Pick List as the recent share price performance has driven the valuation meaningfully ahead of fundamentals. Since early December, FY27 diluted EPS expectations have risen by a...

Guy Sips ... (+5)
  • Guy Sips
  • Jacob Mekhael
  • Mathijs Geerts Danau
  • Wim Hoste
  • Wim Lewi
Wim Hoste
  • Wim Hoste

Akzo Nobel Uninspiring 4Q & FY26 outlook, while Axalta merger can beco...

Akzo's 4Q25 results were roughly in line with previous quarters, with weak volumes and negative FX leading to a slight decline in adjusted EBITDA, despite sizeable efficiency improvement initiatives. 2026 is expected to bring more of the same, with Akzo forecasting flat volumes and an FY26 adjusted EBITDA that is guided to be up at least 2% (or at least 7% excluding negative FX and scope effects). With current efficiency improvement initiatives expected to have mostly run their course in 2027, t...

Wim Lewi
  • Wim Lewi

Elia Group German government agrees on 25.1% Tennet stake

Yesterday, the German government (via KfW) secured a 25.1% "blocking minority" in TenneT's German operations. The €3.3bn deal ends years of negotiations between Germany and the Netherlands. The deal is struck at the same equity value following the capital contribution (46%) from ABP, GIC and Norges Bank in 09/25 at a total equity value of 13.3bn. TenneT NL will hold the remaining 28.9%. We understand from the Handelsblatt that KfW will invest an additional €1.7bn before 2035. TenneT GE will no...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch